Clinical trials update from the American Heart Association meeting: PROSPER, DIAL, home care monitoring trials, immune modulation therapy, COMPANION and anaemia in heart failure

European Journal of Heart Failure

Volumn 5, Issue 1, 2003, Pages 95-99

  Coletta, A P ^a   Nikitin, N ^a   Clark, A L ^a   Cleland, J G F ^a  

^a CASTLE HILL HOSPITAL   (United Kingdom)

Author keywords

Anaemia; COMPANION; DIAL; Heart failure; PROSPER; Telemonitoring

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ETANERCEPT; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INFLIXIMAB; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PRAVASTATIN; UBIDECARENONE;

ANEMIA; CLINICAL RESEARCH; CLINICAL TRIAL; DEFIBRILLATION; HEART FAILURE; HEART PACING; HOME MONITORING; HUMAN; IMMUNOMODULATION; PRIORITY JOURNAL; REVIEW; SIDE EFFECT; TELEMETRY;

AMERICAN HEART ASSOCIATION; ANEMIA; GROUP PROCESSES; HEART FAILURE, CONGESTIVE; HOME CARE SERVICES; HUMANS; IMMUNOTHERAPY; MONITORING, PHYSIOLOGIC; UNITED STATES;

EID: 0037275498     PISSN: 13889842     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1388-9842(02)00249-0     Document Type: Review

References (19)

1. Shepherd J, Cobbe SM, Ford I, et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. (WOSCOPS). N Eng J Med 1995;333:1301-7.
2. Downs JR, Clearfield M, Weis S, et al. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels. Results of AFCAPS/TexCAPS. J Am Med Assoc 1998;279:1615-22.
3. Sacks FM, Pfeffer MA, Moye LA, et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. N Eng J Med 1996;335:1001-9.
4. Shepherd J, Blauw G J, Murphy MB, et al. The design of a prospective study of pravastatin in the elderly at risk (PROSPER). Am J Cardiol 1999;84:1192-7.
5. Shepherd J, Blauw GJ, Murphy MB, et al, Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial. Lancet 2002;360:1623-30.
6. Krum H, McMurray JJ. Statins and chronic heart failure: do we need a large scale outcome trial? J Am Coil Card 2002;39:1567-73.
7. Louis A, Cleland JGF, Crabbe S, Ford S, Thackray S, Houghton T, Clark A. Clinical trials update: CAPRICORN, COPERNICUS, MIRACLE, STAF, RITZ-2, RECOVER and RENAISSANCE and cachexia and cholesterol in heart failure. Highlights of the Scientific Sessions of the American College of Cardiology. Eur J Heart Fail 2001;3:381-7.
8. Louis A, Manousos R, Coletta A, Clark A, Cleland JGF, Clinical trials update: the Heart Protection Study, IONA, CARISA, ENRICHD, ACUTE, ALIVE, MADIT II and REMATCH. Eur J Heart Fail 2002;4:111-6.
9. Coletta AR, Louis AA, Clark AL, Nikitin N, Cleland JGF. Clinical trials update from the European Society of Cardiology: CARMEN, EARTH, OPTIMAAL, ACE, TEN-HMS, MAGIC, SOLVD-X and PATH-CHF II. Eur J Heart Fail 2002;4:661-6.
10. Cleland JGF, Cohen-Solal A, Cosin Aguilar J, et al. For the IMPROVEMENT of heart failure programme committees and investigators and the study group on diagnosis of the working group on heart failure of the European Society of Cardiology. Management of heart failure in primary care (the IMPROVEMENT of Heart Failure Programme): an international survey. Lancet 2002;360:1631-9.
11. Adamopoulos S, Parissis JT, Kremastinos DT. A glossary of circulating cytokines in chronic heart failure. Eur J Heart Fail 2001;3:517-26.
12. Paulus WJ. How are cytokines activated in heart failure? Eur J Heart Fail 1999;1:275-92.
13. Coletta AP, Clark AL, Banarjee P, Cleland JGF. Clinical trials update: RENEWAL (RENAISSANCE and RECOVER) and ATTACH. Eur J Heart Fail 2002;4:559-61.
14. Bristow MR, Feldman AM, Saxon LA. For the COMPANION steering committee and COMPANION clinical investigators. Heart failure management using implantable devices for ventricular resynchronisation: comparison of medical therapy, pacing and defibrillation in chronic heart failure (COMPANION) trial. J Card Fail 2000;6(3):276-85.
15. Cleland JGF, Kappenberger LJ, Tavazzi L, Klein W, Erdmann E. Design and methodology of the CARE-HF trial. A randomised trial of cardiac resynchronisation in patients with heart failure and ventricular dyssynchrony. Eur J Heart Fail 2001;3:481-9.
16. Moss AJ, Zareba W, Hall WJ, et al. for the multicentre automatic defibrillator implantation trial II investigators. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Eng J Med 2002;346:877-83.
17. Cleland JGF, Thackray S, Goodge L, Kaye GC, Cooklin M. Outcome studies with device therapy in patients with heart failure. J Cardiovasc Electrophysiol 2002;13:S73-S91.
18. Cromie N, Lee C, Struthers AD. Anaemia in chronic heart failure: what is its frequency in the UK and its underlying causes? Heart 2002;87:377-8.
19. Silverberg DS, Wexler D, Iaina A. The importance of anaemia and its correction in the management of severe congestive heart failure. Eur J Heart Fail 2002;4(6):681-6.